In 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio industry into the foray of acute care diagnostics.
Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug
Merck licenced xevinapant from Debiopharm International in 2021 in a deal worth $1.08bn. Image Credit: Anne Czichos / Shutterstock Merck KGaA (Merck) has discontinued the